298 related articles for article (PubMed ID: 25551668)
1. High-dose Chemotherapy With Autologous Stem Cell Rescue in Saudi Children Less Than 3 Years of Age With Embryonal Brain Tumors.
Alsultan A; Alharbi M; Al-Dandan S; Bayoumi Y; Alharbi T; Alsudairy R; Alomari A; Aljamaan K; Musleh O; Alharbi Q; Jarrar M
J Pediatr Hematol Oncol; 2015 Apr; 37(3):204-8. PubMed ID: 25551668
[TBL] [Abstract][Full Text] [Related]
2. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
[TBL] [Abstract][Full Text] [Related]
3. Changes in glomerular filtration rate and clinical course after sequential doses of carboplatin in children with embryonal brain tumors undergoing autologous stem cell transplantation.
Elborai Y; Almutereen M; Maher OM; Hafez H; Lee MA; Lehmann L
J Egypt Natl Canc Inst; 2020 Feb; 32(1):9. PubMed ID: 32372349
[TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
Gill P; Litzow M; Buckner J; Arndt C; Moynihan T; Christianson T; Ansell S; Galanis E
Cancer; 2008 Apr; 112(8):1805-11. PubMed ID: 18300237
[TBL] [Abstract][Full Text] [Related]
5. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
Zacharoulis S; Levy A; Chi SN; Gardner S; Rosenblum M; Miller DC; Dunkel I; Diez B; Sposto R; Ji L; Asgharzadeh S; Hukin J; Belasco J; Dubowy R; Kellie S; Termuhlen A; Finlay J
Pediatr Blood Cancer; 2007 Jul; 49(1):34-40. PubMed ID: 16874765
[TBL] [Abstract][Full Text] [Related]
6. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors.
Gardner SL; Asgharzadeh S; Green A; Horn B; McCowage G; Finlay J
Pediatr Blood Cancer; 2008 Aug; 51(2):235-40. PubMed ID: 18381756
[TBL] [Abstract][Full Text] [Related]
7. High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas.
Gururangan S; McLaughlin C; Quinn J; Rich J; Reardon D; Halperin EC; Herndon J; Fuchs H; George T; Provenzale J; Watral M; McLendon RE; Friedman A; Friedman HS; Kurtzberg J; Vredenbergh J; Martin PL
J Clin Oncol; 2003 Jun; 21(11):2187-91. PubMed ID: 12775745
[TBL] [Abstract][Full Text] [Related]
8. Tandem high-dose chemotherapy with topotecan-thiotepa-carboplatin and melphalan-etoposide-carboplatin regimens for pediatric high-risk brain tumors.
Choi JY; Kang HJ; Hong KT; Hong CR; Lee YJ; Park JD; Phi JH; Kim SK; Wang KC; Kim IH; Park SH; Choi YH; Cheon JE; Park KD; Shin HY
Int J Clin Oncol; 2019 Dec; 24(12):1515-1525. PubMed ID: 31352632
[TBL] [Abstract][Full Text] [Related]
9. Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.
Modak S; Gardner S; Dunkel IJ; Balmaceda C; Rosenblum MK; Miller DC; Halpern S; Finlay JL
J Clin Oncol; 2004 May; 22(10):1934-43. PubMed ID: 15143087
[TBL] [Abstract][Full Text] [Related]
10. The impact on outcomes by using thiotepa in tandem transplant for pediatric high-risk embryonal brain tumors.
Yen HJ; Yu TY; Lee CY; Hung GY; Chiou TJ; Chen HH; Lee YY; Liang ML; Chen YW
J Chin Med Assoc; 2019 Feb; 82(2):148-154. PubMed ID: 30839507
[TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors.
Broniscer A; Nicolaides TP; Dunkel IJ; Gardner SL; Johnson J; Allen JC; Sposto R; Finlay JL
Pediatr Blood Cancer; 2004 Mar; 42(3):261-7. PubMed ID: 14752864
[TBL] [Abstract][Full Text] [Related]
12. Choroid plexus carcinoma in children: the Head Start experience.
Zaky W; Dhall G; Khatua S; Brown RJ; Ginn KF; Gardner SL; Yildiz VO; Yankelevich M; Finlay JL
Pediatr Blood Cancer; 2015 May; 62(5):784-9. PubMed ID: 25662896
[TBL] [Abstract][Full Text] [Related]
13. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.
Fangusaro J; Finlay J; Sposto R; Ji L; Saly M; Zacharoulis S; Asgharzadeh S; Abromowitch M; Olshefski R; Halpern S; Dubowy R; Comito M; Diez B; Kellie S; Hukin J; Rosenblum M; Dunkel I; Miller DC; Allen J; Gardner S
Pediatr Blood Cancer; 2008 Feb; 50(2):312-8. PubMed ID: 17668858
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
Nieto Y; Tu SM; Bassett R; Jones RB; Gulbis AM; Tannir N; Kingham A; Ledesma C; Margolin K; Holmberg L; Champlin R; Pagliaro L
Ann Oncol; 2015 Oct; 26(10):2125-32. PubMed ID: 26199392
[TBL] [Abstract][Full Text] [Related]
15. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
Geyer JR; Sposto R; Jennings M; Boyett JM; Axtell RA; Breiger D; Broxson E; Donahue B; Finlay JL; Goldwein JW; Heier LA; Johnson D; Mazewski C; Miller DC; Packer R; Puccetti D; Radcliffe J; Tao ML; Shiminski-Maher T;
J Clin Oncol; 2005 Oct; 23(30):7621-31. PubMed ID: 16234523
[TBL] [Abstract][Full Text] [Related]
16. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of tandem high-dose chemotherapy with autologous peripheral blood stem cell rescue for children with recurrent brain tumors: a Pediatric Blood and MarrowTransplant Consortium study.
Gilman AL; Jacobsen C; Bunin N; Levine J; Goldman F; Bendel A; Joyce M; Anderson P; Rozans M; Wall DA; Macdonald TJ; Simon S; Kadota RP
Pediatr Blood Cancer; 2011 Sep; 57(3):506-13. PubMed ID: 21744474
[TBL] [Abstract][Full Text] [Related]
18. [The European experience with megadose therapy and autologous bone marrow transplantation in solid tumors with poor prognosis Ewing sarcoma, germ cell tumors and brain tumors)].
Ladenstein R; Gadner H; Hartmann O; Pico J; Biron P; Thierry P
Wien Med Wochenschr; 1995; 145(2-3):55-7. PubMed ID: 7762255
[TBL] [Abstract][Full Text] [Related]
19. Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors.
Mason WP; Grovas A; Halpern S; Dunkel IJ; Garvin J; Heller G; Rosenblum M; Gardner S; Lyden D; Sands S; Puccetti D; Lindsley K; Merchant TE; O'Malley B; Bayer L; Petriccione MM; Allen J; Finlay JL
J Clin Oncol; 1998 Jan; 16(1):210-21. PubMed ID: 9440745
[TBL] [Abstract][Full Text] [Related]
20. Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy.
Finkelstein-Shechter T; Gassas A; Mabbott D; Huang A; Bartels U; Tabori U; Janzen L; Hawkins C; Taylor M; Bouffet E
J Pediatr Hematol Oncol; 2010 Jul; 32(5):e182-6. PubMed ID: 20495479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
